Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis.
Mutations in the rpoB gene were associated with rifampicin resistance in clinical S. epidermidis isolates.
In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.
Mutations in rpoB confer resistance to rifampin.
Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain.
Additional mutations in rpoB are associated with high-level rifampicin resistance
RNA polymerase B subunit gene mutations in biofilm-embedded methicillin-resistant Staphylococcus aureus following rifampin treatment.
Mutations in the rpoB gene were associated with rifampin resistance in biofilm-embedded MRSA isolates.
Comprehensive antibiotic-linked mutation assessment by resistance mutation sequencing (RM-seq).
Confirmed by genetic reconstruction
Convergent Evolution Driven by Rifampin Exacerbates the Global Burden of Drug-Resistant Staphylococcus aureus.
All mutations were validated via reconstruction in an isogenic background and MIC testing.
Rifampicin resistance in Staphylococcus epidermidis: molecular characterisation and fitness cost of rpoB mutations.
rpoB
Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus.
Staphylococcus aureus rpoB mutants conferring resistance to rifampicin; CARD accession: CARD:3003285
Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research